Overview

Bimatoprost as a Treatment for Graves' Orbitopathy

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Washington
Treatments:
Bimatoprost